“Proteins are the machines of life and we found that antibodies give you a wonderful means of examining the machines of life,” Springer toldSpringer says the donation will help scale the institute, bring in new technologies and recruit a higher caliber of professionals. He said the donation was made via a gift of shares he owns in a variety of biotech companies, including Moderna.
Springer decided to launch the institute after a postdoctoral fellowship at the University of Cambridge, in England, with César Milstein, an Argentine biochemist who received the Nobel Prize for his work with antibody technology. Springer continued building on their discoveries once he returned to the United States but he says the technology was only available at for-profit companies, inspiring him to expand into the nonprofit sector.
Springer, who sits on the board of IPI, has been long involved in the biotech industry. In addition to his founding stake in Moderna, he owns stakes in Selecta Biosciences, Scholar Rock and Morphic Therapeutic. He’s also the founder of and investor in two private companies, Seismic Therapeutics and Tectonic Therapeutics.
Technology Technology Latest News, Technology Technology Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: IntEngineering - 🏆 287. / 63 Read more »